Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jakub Visek"'
Autor:
Ivone Cristina Igreja Sa, Ctirad Andrýs, K. Tripská, Miriam Lánská, Petr Nachtigal, M. Vicen, Milan Bláha, M. Lasticova, Iveta Najmanová, J. Duintjer Tebbens, Vladimír Bláha, Jakub Visek
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Lipoprotein apheresis (LA) is considered as an add-on therapy for patients with familial hypercholesterolemia (FH). We aimed to analyze the data collected in the last 15 years from FH patients treated with LA, to elucidate the benefit of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39efd573d86248ccf011a9705fb2e06e
https://doaj.org/article/d2c0719983cd4723aee673f6b614b3ea
https://doaj.org/article/d2c0719983cd4723aee673f6b614b3ea
Publikováno v:
Vnitřní lékařství. 66:438-442
Laktatova acidoza je obavanou komplikaci lecby metforminem. V clanku předkladame kazuistiku dvou pacientek lecených metforminem, u kterých se tato zavažna komplikace vyskytla. V prvnim připadě doslo ke kumulaci laktatu v důsledku rozvoje akutn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::369039d990c35cff9f4f652f1657e306
https://doi.org/10.36290/vnl.2020.124
https://doi.org/10.36290/vnl.2020.124
Publikováno v:
Vnitřní lékařství. 66:15-20
Aterogenni dyslipidemie rozhodujicim způsobem ovlivňuje kardiovaskularni riziko postižených jedinců. V jeji patofyziologii se uplatňuje inzulinova rezistence, ktera vyvolava nadprodukci aterogennich lipoproteinů o velmi nizke hustotě (very lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8620fde1c215d2bebd6f4b92b9c54b60
https://doi.org/10.36290/vnl.2020.003
https://doi.org/10.36290/vnl.2020.003
Autor:
Dana Dlouha, Milan Blaha, Eva Rohlova, Jaroslav A. Hubacek, Vera Lanska, Jakub Visek, Vladimir Blaha
Publikováno v:
Genes
Volume 12
Issue 10
Genes, Vol 12, Iss 1599, p 1599 (2021)
Volume 12
Issue 10
Genes, Vol 12, Iss 1599, p 1599 (2021)
Familial hypercholesterolemia (FH), is an autosomal dominant disorder caused by mutations in the LDLR, APOB, PCSK9, and APOE genes and is characterized by high plasma levels of total and low-density lipoprotein (LDL) cholesterol. Our study aimed to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::03fa3fbb4b5303d1dbb2d7b2cc060659
http://europepmc.org/articles/PMC8535274
http://europepmc.org/articles/PMC8535274
Autor:
M. Vicen, M. Lasticova, K. Tripská, Ctirad Andrýs, I. C. Igreja Sá, Miriam Lánská, Petr Nachtigal, Jurjen Duintjer Tebbens, Milan Bláha, Jakub Visek, Vladimír Bláha
Publikováno v:
Atherosclerosis. 331:e135-e136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0cb916a2672aeae11a2cbb9e173c5d8
https://doi.org/10.1016/j.atherosclerosis.2021.06.405
https://doi.org/10.1016/j.atherosclerosis.2021.06.405
Autor:
Roman Safranek, Michaela Kubisova, Lydia Habanova, Petr Moucka, Jakub Visek, Marta Kalousova, Miroslav Merta, Lubos Sobotka, Sylvie Dusilova Sulkova
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 2, p A70 (2012)
Fetuin-A is a calcification inhibitor, negative acute phase response marker and cardiovascular mortality predictor in hemodialysis patients. Low levels of fetuin-A are associated with malnutrition, inflammation, decreased bone mass density, low-turno
Externí odkaz:
https://doaj.org/article/82d7e11f61df467c8eccf1c0b4581c6d
Publikováno v:
Atherosclerosis. 315:e111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd42de6f1ac4f1adf3f20c618407e1ad
https://doi.org/10.1016/j.atherosclerosis.2020.10.338
https://doi.org/10.1016/j.atherosclerosis.2020.10.338
Autor:
Jakub Visek, M. Lasticova, Miriam Lánská, Milan Bláha, Petr Nachtigal, Vladimír Bláha, Eva Dolezelova
Publikováno v:
Atherosclerosis. 287:e264-e265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f64b39b1885b00b7b388690433f57fa
https://doi.org/10.1016/j.atherosclerosis.2019.06.818
https://doi.org/10.1016/j.atherosclerosis.2019.06.818
Autor:
Alena Prasnicka, Petr Nachtigal, Alena Ticha, Jolana Cermanova, Radomír Hyšpler, Miguel Pericacho, M. Lasticova, Stanislav Micuda, Jakub Visek, Hana Lastuvkova, Ivone Cristina Igreja Sa, Milos Hroch, Eva Dolezelova
Publikováno v:
Life Sciences. 232:116643
Aims Increased plasma soluble endoglin concentrations (sEng) are frequently detected in metabolic disorders accompanied with hypercholesterolemia in serum, but effect of sEng on the cholesterol biochemistry is unknown. Cholesterol and bile acids (BA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbdd1aa27fc41cc1d6641ec68ebada5
https://doi.org/10.1016/j.lfs.2019.116643
https://doi.org/10.1016/j.lfs.2019.116643
Autor:
Jakub Visek, Miriam Lánská, M. Lasticova, Vladimír Bláha, Eva Dolezelova, Milan Bláha, Petr Nachtigal
Publikováno v:
Atherosclerosis. 287:e265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4fef67a80dac46e5b2054d0013402ae
https://doi.org/10.1016/j.atherosclerosis.2019.06.819
https://doi.org/10.1016/j.atherosclerosis.2019.06.819